Keyword Analysis & Research: cuban interferon alpha 2b

nih.gov

https://pubmed.ncbi.nlm.nih.gov/33337933/

WEBAbstract. A previous report on 814 patients who were coronavirus disease 2019 (COVID-19) positive provided preliminary therapeutic efficacy evidence with interferon-α2b (IFN … Author: Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del... Publish Year: 2020

Author: Ricardo Pereda, Daniel González, Hubert Blas Rivero, Juan Carlos Rivero, Albadio Pérez, Lissette Del...

Publish Year: 2020

DA: 13 PA: 45 MOZ Rank: 8

medigraphic.com

https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=75882

WEBABSTRACT. Since 1986, the Center for Genetic Engineering and Biotechnology of Havana, Cuba, has produced the recombinant human interferon alpha-2b, marketed as … Author: Hugo Nodarse-Cuní, Pedro A López-Saura Publish Year: 2017

Author: Hugo Nodarse-Cuní, Pedro A López-Saura

Publish Year: 2017

DA: 2 PA: 36 MOZ Rank: 56

researchgate.net

https://www.researchgate.net/publication/320503667_Cuban_interferon_alpha-2b_Thirty_years_as_an_effective_and_safe_drug

WEBPDF | On Mar 1, 2017, Hugo Nodarse-Cuní and others published Cuban interferon alpha-2b. Thirty years as an effective and safe drug | Find, read and cite all the research you …

DA: 16 PA: 99 MOZ Rank: 86

medrxiv.org

https://www.medrxiv.org/content/10.1101/2020.05.29.20109199v1.full.pdf

WEBMay 29, 2020 · Heberon® Alpha R (human recombinant IFN-α2b) produced by the Center for Genetic Engineering and Biotechnology, Havana, Cuba, has demonstrated antiviral …

DA: 21 PA: 95 MOZ Rank: 64

semanticscholar.org

https://www.semanticscholar.org/paper/Cuban-interferon-alpha-2-b-.-Thirty-years-as-an-and-Nodarse-Cun%C3%AD-L%C3%B3pez-Saura/032a27cee642fa43eced5b3649b6fb1dace9166b

WEBCuban interferon alpha-2 b . Thirty years as an effective and safe drug. H. Nodarse-Cuní, P. López-Saura. Published 2017. Medicine. TLDR. The extensive clinical information …

DA: 61 PA: 80 MOZ Rank: 7

nih.gov

https://pubmed.ncbi.nlm.nih.gov/33337933/

DA: 63 PA: 6 MOZ Rank: 92

medrxiv.org

https://www.medrxiv.org/content/10.1101/2020.07.28.20157974v1

WEBAug 4, 2020 · Conclusions This second report confirm the preliminary evidences from first for the therapeutic effectiveness of IFNα-2b for SARS-Cov-2 infection and postulated …

DA: 49 PA: 81 MOZ Rank: 48

medrxiv.org

https://www.medrxiv.org/content/10.1101/2020.07.28.20157974v1.full.pdf

WEBJul 28, 2020 · Cuba provided preliminary therapeutic efficacy evidence with interferon-α2b (IFN-α2b) from March. 11 to April 14, 2020. This study, re-evaluates the contribution of …

DA: 49 PA: 19 MOZ Rank: 80

semanticscholar.org

https://www.semanticscholar.org/paper/Therapeutic-effectiveness-of-interferon-alpha-2b-Pereda-Gonz%C3%A1lez/2c607611776b93e0ba77d346fd4f3d071645becf

WEBA previous report in 814 patients COVID-19 positive in Cuba provided preliminary therapeutic efficacy evidence with interferon alpha-2b (IFN alpha-2b) from March 11 to …

DA: 43 PA: 69 MOZ Rank: 14

liebertpub.com

https://www.liebertpub.com/doi/10.1089/jir.2020.0188

WEBDec 16, 2020 · A previous report on 814 patients who were coronavirus disease 2019 (COVID-19) positive provided preliminary therapeutic efficacy evidence with interferon …

DA: 42 PA: 56 MOZ Rank: 37